ASCLEPIOS · COMB157G2302

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis. EudraCT: 2015-005419-33.

Sponsor: NOVARTIS

Phase: III

Area: Neuroimmunology

Open the current study catalogue